159 related articles for article (PubMed ID: 26618805)
1. VERY EARLY DISEASE MANIFESTATIONS OF MACULAR TELANGIECTASIA TYPE 2.
Charbel Issa P; Heeren TF; Kupitz EH; Holz FG; Berendschot TT
Retina; 2016 Mar; 36(3):524-34. PubMed ID: 26618805
[TBL] [Abstract][Full Text] [Related]
2. Comparison of cone pathologic changes in idiopathic macular telangiectasia types 1 and 2 using adaptive optics scanning laser ophthalmoscopy.
Ooto S; Hangai M; Takayama K; Ueda-Arakawa N; Tsujikawa A; Yamashiro K; Oishi A; Hanebuchi M; Yoshimura N
Am J Ophthalmol; 2013 Jun; 155(6):1045-1057.e4. PubMed ID: 23465268
[TBL] [Abstract][Full Text] [Related]
3. High-resolution photoreceptor imaging in idiopathic macular telangiectasia type 2 using adaptive optics scanning laser ophthalmoscopy.
Ooto S; Hangai M; Takayama K; Arakawa N; Tsujikawa A; Koizumi H; Oshima S; Yoshimura N
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5541-50. PubMed ID: 21642620
[TBL] [Abstract][Full Text] [Related]
4. First symptoms and their age of onset in macular telangiectasia type 2.
Heeren TF; Holz FG; Charbel Issa P
Retina; 2014 May; 34(5):916-9. PubMed ID: 24351446
[TBL] [Abstract][Full Text] [Related]
5. Multimodal imaging in type 2 idiopathic macular telangiectasia.
Sallo FB; Leung I; Clemons TE; Peto T; Bird AC; Pauleikhoff D
Retina; 2015 Apr; 35(4):742-9. PubMed ID: 25412037
[TBL] [Abstract][Full Text] [Related]
6. Retinal structural alterations and macular sensitivity in idiopathic macular telangiectasia type 1.
Takayama K; Ooto S; Tamura H; Yamashiro K; Otani A; Tsujikawa A; Yoshimura N
Retina; 2012 Oct; 32(9):1973-80. PubMed ID: 22487581
[TBL] [Abstract][Full Text] [Related]
7. Correlation of functional impairment and morphological alterations in patients with group 2A idiopathic juxtafoveal retinal telangiectasia.
Schmitz-Valckenberg S; Fan K; Nugent A; Rubin GS; Peto T; Tufail A; Egan C; Bird AC; Fitzke FW
Arch Ophthalmol; 2008 Mar; 126(3):330-5. PubMed ID: 18332311
[TBL] [Abstract][Full Text] [Related]
8. Correlation of macular function with retinal thickness in nonproliferative type 2 idiopathic macular telangiectasia.
Charbel Issa P; Helb HM; Holz FG; Scholl HP;
Am J Ophthalmol; 2008 Jan; 145(1):169-175. PubMed ID: 17981256
[TBL] [Abstract][Full Text] [Related]
9. CONE DENSITY LOSS ON ADAPTIVE OPTICS IN EARLY MACULAR TELANGIECTASIA TYPE 2.
Jacob J; Krivosic V; Paques M; Tadayoni R; Gaudric A
Retina; 2016 Mar; 36(3):545-51. PubMed ID: 26418443
[TBL] [Abstract][Full Text] [Related]
10. Macular Pigment Distribution as Prognostic Marker for Disease Progression in Macular Telangiectasia Type 2.
Müller S; Charbel Issa P; Heeren TFC; Thiele S; Holz FG; Herrmann P
Am J Ophthalmol; 2018 Oct; 194():163-169. PubMed ID: 30053477
[TBL] [Abstract][Full Text] [Related]
11. Perception of Haidinger Brushes in Macular Disease Depends on Macular Pigment Density and Visual Acuity.
Müller PL; Müller S; Gliem M; Küpper K; Holz FG; Harmening WM; Charbel Issa P
Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1448-56. PubMed ID: 27028066
[TBL] [Abstract][Full Text] [Related]
12. Type 2 idiopathic macular telangiectasia.
Shukla D; Gupta SR; Neelakantan N; Tiwari S; Gupta S; Patwardhan AR; Soubhya TB
Retina; 2012 Feb; 32(2):265-74. PubMed ID: 21968508
[TBL] [Abstract][Full Text] [Related]
13. EARLY SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY BIOMARKERS TO CONFIRM FELLOW EYE CHANGES IN ASYMMETRIC TYPE-2 MACULAR TELANGIECTASIA: A Case-Control Study (India Macular Telangiectasia Report 1).
Alex D; Giridhar A; Gopalakrishnan M; Manayath G; Amar S; Raman R; Sreenivasan R; Ayachit A; Sivaprasad S
Retina; 2021 Mar; 41(3):471-479. PubMed ID: 32804830
[TBL] [Abstract][Full Text] [Related]
14. Dark-Adapted Two-Color Fundus-Controlled Perimetry in Macular Telangiectasia Type 2.
Heeren TFC; Tzaridis S; Bonelli R; Pfau M; Fruttiger M; Okada M; Egan C; Charbel Issa P; Holz FG
Invest Ophthalmol Vis Sci; 2019 Apr; 60(5):1760-1767. PubMed ID: 31022297
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal bevacizumab for treatment of proliferative and nonproliferative type 2 idiopathic macular telangiectasia.
Roller AB; Folk JC; Patel NM; Boldt HC; Russell SR; Abramoff MD; Mahajan VB
Retina; 2011 Oct; 31(9):1848-55. PubMed ID: 21610563
[TBL] [Abstract][Full Text] [Related]
16. Macular Telangiectasia Type 2 Without Clinically Detectable Vasculopathy.
Gillies MC; Mehta H; Bird AC
JAMA Ophthalmol; 2015 Aug; 133(8):951-4. PubMed ID: 26067680
[TBL] [Abstract][Full Text] [Related]
17. "En face" optical coherence tomography imaging in type 2 idiopathic macular telangiectasia.
Wolff B; Basdekidou C; Vasseur V; Sahel JA; Gaudric A; Mauget-Faÿsse M
Retina; 2014 Oct; 34(10):2072-8. PubMed ID: 25255245
[TBL] [Abstract][Full Text] [Related]
18. [Functional characteristics of macular telangiectasia type 2].
Heeren TF; Krüger E; Holz FG; Charbel Issa P
Ophthalmologe; 2014 Sep; 111(9):829-33. PubMed ID: 25204528
[TBL] [Abstract][Full Text] [Related]
19. Visual function in patients with idiopathic macular telangiectasia type 1.
Sugiura Y; Okamoto F; Okamoto Y; Hiraoka T; Oshika T
Acta Ophthalmol; 2016 Nov; 94(7):e672-e673. PubMed ID: 27230481
[No Abstract] [Full Text] [Related]
20. Multimodal imaging of the macula in hereditary and acquired lack of macular pigment.
Theelen T; Berendschot TT; Klevering BJ; Fuijkschot J; Hoyng CB; Willemsen MA
Acta Ophthalmol; 2014 Mar; 92(2):138-42. PubMed ID: 23387297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
